These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28756644)

  • 1. The role of anaplastic lymphoma kinase in pediatric cancers.
    Takita J
    Cancer Sci; 2017 Oct; 108(10):1913-1920. PubMed ID: 28756644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
    Kelleher FC; McDermott R
    Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date.
    Lowe EJ; Lim MS
    Paediatr Drugs; 2013 Jun; 15(3):163-9. PubMed ID: 23696342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma.
    Cheng M; Ott GR
    Anticancer Agents Med Chem; 2010 Mar; 10(3):236-49. PubMed ID: 20406193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.
    McDermott U; Iafrate AJ; Gray NS; Shioda T; Classon M; Maheswaran S; Zhou W; Choi HG; Smith SL; Dowell L; Ulkus LE; Kuhlmann G; Greninger P; Christensen JG; Haber DA; Settleman J
    Cancer Res; 2008 May; 68(9):3389-95. PubMed ID: 18451166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer.
    Katayama R
    Cancer Sci; 2018 Mar; 109(3):572-580. PubMed ID: 29336091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
    van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
    Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
    Vishwamitra D; Li Y; Wilson D; Manshouri R; Curry CV; Shi B; Tang XM; Sheehan AM; Wistuba II; Shi P; Amin HM
    Am J Pathol; 2012 May; 180(5):1772-80. PubMed ID: 22414602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic lymphoma kinase gene expression in small round cell tumors of childhood--a comparative ımmunohistochemical study.
    Karakuş E; Emir S; Kaçar A; Karakuş R; Demir HA; Özyörük D
    Ann Diagn Pathol; 2015 Aug; 19(4):239-42. PubMed ID: 26005112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic lymphoma kinase: signalling in development and disease.
    Palmer RH; Vernersson E; Grabbe C; Hallberg B
    Biochem J; 2009 May; 420(3):345-61. PubMed ID: 19459784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
    Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
    EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.
    Okubo J; Takita J; Chen Y; Oki K; Nishimura R; Kato M; Sanada M; Hiwatari M; Hayashi Y; Igarashi T; Ogawa S
    Oncogene; 2012 Nov; 31(44):4667-76. PubMed ID: 22249260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origins of ALK translocations.
    Roukos V; Mathas S
    Front Biosci (Schol Ed); 2015 Jun; 7(2):260-8. PubMed ID: 25961701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaplastic lymphoma kinase: Role in cancer and therapy perspective.
    Zhao Z; Verma V; Zhang M
    Cancer Biol Ther; 2015; 16(12):1691-701. PubMed ID: 26529396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-immunoreactive neoplasms.
    Minoo P; Wang HY
    Int J Clin Exp Pathol; 2012; 5(5):397-410. PubMed ID: 22808292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.
    Fukuhara S; Nomoto J; Kim SW; Taniguchi H; Miyagi Maeshima A; Tobinai K; Kobayashi Y
    Hematol Oncol; 2018 Feb; 36(1):150-158. PubMed ID: 28665006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
    Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
    J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine.
    Katayama R; Lovly CM; Shaw AT
    Clin Cancer Res; 2015 May; 21(10):2227-35. PubMed ID: 25979929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting anaplastic lymphoma kinase in lung cancer.
    Shaw AT; Solomon B
    Clin Cancer Res; 2011 Apr; 17(8):2081-6. PubMed ID: 21288922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies.
    Mossé YP
    Clin Cancer Res; 2016 Feb; 22(3):546-52. PubMed ID: 26503946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.